Publications by authors named "David Damoiseaux"

Claim this Profile
E
Early Prediction and Impact Assessment of CYP3A4-Related Drug-Drug Interactions for Small-Molecule Anticancer Drugs Using Human-CYP3A4-Transgenic Mouse Models.
David Damoiseaux, Jos H Beijnen, Alwin D R Huitema, Thomas P C Dorlo

Drug Metab Dispos· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictability of human exposure by human-CYP3A4-transgenic mouse models: A meta-analysis.
David Damoiseaux, Alfred H Schinkel, Jos H Beijnen, Alwin D R Huitema, Thomas P C Dorlo

Clin Transl Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiologically-based pharmacokinetic model to predict doxorubicin and paclitaxel exposure in infants through breast milk.
David Damoiseaux, Frédéric Amant, Jos H Beijnen, Shelby Barnett, Gareth J Veal

CPT Pharmacometrics Syst Pharmacol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High accumulation of nivolumab in human breast milk: A case report.
Karen de Jong, David Damoiseaux, Dick Pluim, Hilde Rosing, Jos H Beijnen

Biomed Pharmacother· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Chemotherapy Distribution into Breast Milk for Breastfeeding Women Using a Population Pharmacokinetic Approach.
David Damoiseaux, Daniel Centanni, Jos H Beijnen, Frédéric Amant, Alwin D R Huitema

Clin Pharmacokinet· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of Five Chemotherapeutic Drugs in Breast Milk as a Guide for the Safe Use of Chemotherapy During Breastfeeding: Results From a Case Series.
David Damoiseaux, Silvia Calpe, Hilde Rosing, Jos H Beijnen, Alwin D R Huitema

Clin Pharmacol Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictiveness of the Human-CYP3A4-Transgenic Mouse Model (Cyp3aXAV) for Human Drug Exposure of CYP3A4-Metabolized Drugs.
David Damoiseaux, Wenlong Li, Alejandra Martínez-Chávez, Jos H Beijnen, Alfred H Schinkel

Pharmaceuticals (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetic Modelling to Support the Evaluation of Preclinical Pharmacokinetic Experiments with Lorlatinib.
David Damoiseaux, Wenlong Li, Jos H Beijnen, Alfred H Schinkel, Alwin D R Huitema

J Pharm Sci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 Dose-Escalation Study of Low-Dose Metronomic Treatment With Novel Oral Paclitaxel Formulations in Combination With Ritonavir in Patients With Advanced Solid Tumors.
Vincent A de Weger, Marit A C Vermunt, Frederik E Stuurman, Artur M Burylo, David Damoiseaux

Clin Pharmacol Drug Dev· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis